Heron Therapeutics to Present Data From Completed Phase 3 MAGIC Study of SUSTOL® at ASCO Breast Cancer Symposium
Go back to Heron Therapeutics to Present Data From Completed Phase 3 MAGIC Study of SUSTOL® at ASCO Breast Cancer Symposium| HERON THERAPEUTICS (NASDAQ: HRTX) | Delayed: 0.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $31.32 | |||
| Open | $0.43 | 52 Week Low | $13.95 | |||
| Day High | $0.44 | P/E | N/A | |||
| Day Low | $0.43 | EPS | $-3.29 | |||
| Volume | 984,187 | |||||
